Capacity_expansion_OASIS

Boehringer Ingelheim Biopharmaceuticals China expands commercial manufacturing capacitiesExpansion of manufacturing capacities in OASIS facilityIncreasing demands for world-class manufacturing in Shanghai, ChinaFirst commercial product manufacturing in Shanghai expected in 2019 

Source: Boehringer Ingelheim Corporate News - January 17, 2019 Category: Research Source Type: news